Batch BeaconUK recalls and safety alerts

Device safety informationMHRA

Paclitaxel coated devices (PCD) used safety warning over a safety concern

Device safety concern

Following a review, the MHRA has updated previous guidance (DSI/2022/003) on the use of paclitaxel coated devices (PCD) in the treatment of peripheral arterial disease (PAD).

What to do now

Users of Paclitaxel coated devices (PCD) used in the treatment of peripheral are asked to act on new safety information.

  1. Speak to the clinic, hospital or supplier who gave you the device before changing how you use it.
  2. Check the model, lot or serial number against the details on this page.
  3. Any incident involving the device can be reported through the Yellow Card scheme.

Why it matters. Device safety information tells healthcare staff and, where relevant, patients about risks and the actions needed.

Replacements and support

Speak to the supplier, clinic or hospital that gave you the device. They will know whether yours is affected and what happens next.

Do not throw away a device you rely on until a replacement has been arranged.

From the official notice

Published by the Medicines and Healthcare products Regulatory Agency (DSI/2024/001). Quoted as issued.

Summary

Following a review, the MHRA has updated previous guidance (DSI/2022/003) on the use of paclitaxel coated devices (PCD) in the treatment of peripheral arterial disease (PAD).

The risk

Devices Details Device Name: Paclitaxel coated devices (PCD) used in the treatment of lower limb vascular stenosis / peripheral arterial disease (PAD) Affected lot numbers/serial numbers: All makes / models

Advice for healthcare professionals

Paclitaxel coated devices (PCD) can be considered (where indicated) as a clinical treatment option for patients experiencing peripheral arterial disease (PAD), including patients with critical limb ischemia (CLI) or intermittent claudication (IC)

Previous MHRA advice relating to the use of the lowest dose PCD available and to avoid/reduce repeated exposure of paclitaxel coated devices is withdrawn

Routine patient follow-up should continue as per standard of care

Direct any suspected adverse incidents associated with PCD to your national reporting system. Healthcare professionals should report incidents:

in England and Wales to the Yellow Card scheme or via the Yellow Card app

in Scotland to Incident Reporting & Investigation Centre (IRIC) and their local incident recording system

in Northern Ireland to the Northern Ireland Adverse Incident Centre and their local incident recording system

When reporting suspected adverse incidents, please include the following information:

details of the device, including manufacturer, model, and batch number

details of problems with the device and when the problems started

To assist with the capture of long-term, high quality follow-up outcomes data for possible future evaluation, please ensure details are completed utilising the National Vascular Registry (NVR) and also the Outcomes and Registries Programme (ORP) for follow-up outcomes in England.

NVR Data Entry System/VSQIP

Advice for patients

The advice in this notice is aimed at the healthcare professionals and teams who are responsible for providing and monitoring medical devices used to treat peripheral arterial disease

No new safety concerns have been identified for patients

If you or somebody in your care has received one of these devices and are concerned, please contact your GP, or your local vascular services / consultant for advice

Open the MHRA notice

Questions

Why has Paclitaxel coated devices (PCD) used in the treatment of peripheral been recalled?

Users of Paclitaxel coated devices (PCD) used in the treatment of peripheral are asked to act on new safety information. Device safety information tells healthcare staff and, where relevant, patients about risks and the actions needed.

How do I know if my product is affected?

The notice describes the affected product rather than listing codes. Compare the product name, pack size and where you bought it with the official notice.

What should I do now?

Speak to the clinic, hospital or supplier who gave you the device before changing how you use it. Check the model, lot or serial number against the details on this page.

Who replaces the device?

Speak to the supplier, clinic or hospital that gave you the device. They will know whether yours is affected and what happens next. Do not throw away a device you rely on until a replacement has been arranged.

Related notices